Wednesday, November 16, 2022

Reply to Letter to the Editor on disease severity and efficacy of homologous vaccination among patients infected with SARS‐CoV‐2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers

alexandrossfakianakis shared this article with you from Inoreader

Abstract

We appreciate the commenters' interest in our article detailing the "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers

This article is protected by copyright. All rights reserved.

View on Web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...